EVEROLIMUS

EVEROLIMUS was reported 39594 times

EVEROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 71 0.4437
1 PIK3CA-ACTIVATED MUTATION 54 0.3699
2 ANGIOFIBROMA 25 0.3676
3 INFUSION SITE COLDNESS 23 0.3485
4 POLYOMAVIRUS VIRAEMIA 78 0.2484
5 PANCREATIC NEUROENDOCRINE TUMOUR 98 0.2456
6 BRAIN STEM GLIOMA 20 0.2299
7 NEUROENDOCRINE TUMOUR 190 0.2023
8 ASTROCYTOMA, LOW GRADE 20 0.1802
9 BLOOD CHROMOGRANIN A INCREASED 56 0.1687
10 CARCINOID CRISIS 27 0.1588
11 GAMMA-GLUTAMYLTRANSFERASE DECREASED 24 0.1569
12 METASTASES TO SKIN 98 0.1474
13 ANGIOMYOLIPOMA 24 0.1395
14 CARCINOID TUMOUR PULMONARY 23 0.1345
15 METASTASES TO CHEST WALL 29 0.1295
16 CARBOHYDRATE ANTIGEN 15-3 INCREASED 50 0.1289
17 METASTASES TO PLEURA 76 0.1246
18 METASTASES TO THE MEDIASTINUM 36 0.1220
19 METASTASES TO THORAX 20 0.1130
20 HUMAN POLYOMAVIRUS INFECTION 36 0.1094
21 PSEUDOCIRRHOSIS 19 0.0995
22 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 124 0.0949
23 LYMPHANGIOSIS CARCINOMATOSA 70 0.0931
24 PARVOVIRUS B19 INFECTION 30 0.0915
25 METASTASES TO PANCREAS 26 0.0900
26 METASTASES TO BONE 834 0.0842
27 VIRAEMIA 66 0.0837
28 METASTASES TO LIVER 959 0.0819
29 BK VIRUS INFECTION 156 0.0818
30 METASTATIC RENAL CELL CARCINOMA 132 0.0815
31 TUMOUR MARKER INCREASED 219 0.0779
32 CELL MARKER INCREASED 34 0.0756
33 BREAST CANCER METASTATIC 558 0.0753
34 METASTASES TO LUNG 543 0.0727
35 METASTASES TO KIDNEY 31 0.0723
36 STOMATITIS 2811 0.0709
37 ONCOLOGIC COMPLICATION 42 0.0705
38 METASTASES TO ADRENALS 43 0.0687
39 METASTASES TO PERITONEUM 98 0.0632
40 METASTASES TO SPINE 135 0.0625
41 HEPATITIS E 61 0.0619
42 APHTHOUS ULCER 234 0.0618
43 METASTASES TO LYMPH NODES 256 0.0607
44 HUMAN HERPESVIRUS 8 INFECTION 19 0.0599
45 MALIGNANT NEOPLASM PROGRESSION 3795 0.0599
46 LYMPHOCELE 35 0.0597
47 PNEUMONITIS 985 0.0588
48 CARCINOID TUMOUR 31 0.0586
49 HEPATIC LESION 170 0.0584
50 RENAL TUBULAR ATROPHY 34 0.0546
51 ABDOMINAL LYMPHADENOPATHY 27 0.0529
52 DEVICE RELATED THROMBOSIS 27 0.0516
53 TUMOUR PAIN 45 0.0495
54 CONCOMITANT DISEASE PROGRESSION 84 0.0481
55 LUNG TRANSPLANT REJECTION 22 0.0479
56 RENAL CANCER METASTATIC 30 0.0478
57 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 43 0.0474
58 LIVER TRANSPLANT REJECTION 66 0.0465
59 HEART TRANSPLANT REJECTION 36 0.0444
60 DELAYED GRAFT FUNCTION 19 0.0438
61 CLEAR CELL RENAL CELL CARCINOMA 19 0.0435
62 ORAL PAIN 680 0.0420
63 NEOPLASM PROGRESSION 899 0.0407
64 MALIGNANT PLEURAL EFFUSION 49 0.0407
65 NONINFECTIVE GINGIVITIS 32 0.0403
66 MALIGNANT ASCITES 22 0.0398
67 LYMPHADENOPATHY MEDIASTINAL 50 0.0389
68 RENAL TRANSPLANT FAILURE 24 0.0388
69 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 108 0.0385
70 POST-TRAUMATIC NECK SYNDROME 23 0.0385
71 HEPATIC NEOPLASM 93 0.0382
72 METASTASIS 178 0.0380
73 COMPLICATIONS OF TRANSPLANTED KIDNEY 64 0.0379
74 RENAL CELL CARCINOMA 141 0.0377
75 SECOND PRIMARY MALIGNANCY 214 0.0370
76 MOUTH ULCERATION 517 0.0366
77 BILE DUCT STENOSIS 32 0.0365
78 BREAST CANCER RECURRENT 79 0.0365
79 MEAN CELL HAEMOGLOBIN DECREASED 41 0.0360
80 MOUTH INJURY 38 0.0356
81 INFUSION SITE INDURATION 22 0.0355
82 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 19 0.0353
83 TUMOUR NECROSIS 26 0.0343
84 KIDNEY FIBROSIS 42 0.0341
85 MUCOSAL INFLAMMATION 619 0.0341
86 BONE NEOPLASM 26 0.0327
87 CANCER PAIN 50 0.0324
88 BONE LESION 81 0.0319
89 TRANSPLANT REJECTION 176 0.0318
90 DRUG LEVEL DECREASED 183 0.0314
91 CARCINOEMBRYONIC ANTIGEN INCREASED 37 0.0309
92 HEPATIC MASS 38 0.0308
93 REFLUX GASTRITIS 22 0.0294
94 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 58 0.0291
95 METASTASES TO CENTRAL NERVOUS SYSTEM 227 0.0286
96 APHTHOUS STOMATITIS 66 0.0285
97 HYPERTRIGLYCERIDAEMIA 112 0.0280
98 PANCREATIC NEOPLASM 25 0.0279
99 LYMPHOEDEMA 120 0.0267
100 KIDNEY TRANSPLANT REJECTION 101 0.0266
101 LUNG INFILTRATION 201 0.0265
102 CONCOMITANT DISEASE AGGRAVATED 121 0.0264
103 PANCREATIC MASS 19 0.0261
104 METASTASES TO MENINGES 33 0.0256
105 INVASIVE DUCTAL BREAST CARCINOMA 47 0.0256
106 NEOPLASM 186 0.0252
107 RECURRENT CANCER 58 0.0252
108 LUNG CONSOLIDATION 51 0.0247
109 RENAL NEOPLASM 36 0.0243
110 CREPITATIONS 56 0.0235
111 ORAL MUCOSAL BLISTERING 107 0.0233
112 ORAL MUCOSAL EXFOLIATION 27 0.0233
113 CHOLANGITIS 90 0.0231
114 TONGUE ULCERATION 58 0.0228
115 NAIL DISORDER 119 0.0224
116 BODY TEMPERATURE DECREASED 154 0.0213
117 ONYCHOCLASIS 96 0.0212
118 ASCITES 441 0.0208
119 BLOOD PRESSURE SYSTOLIC INCREASED 255 0.0206
120 CACHEXIA 77 0.0205
121 URETERIC OBSTRUCTION 21 0.0203
122 BILIARY DILATATION 22 0.0199
123 BLOOD CREATININE DECREASED 42 0.0198
124 PLEURAL EFFUSION 883 0.0196
125 PNEUMOCYSTIS JIROVECII PNEUMONIA 114 0.0196
126 HYPOPHOSPHATAEMIA 93 0.0196
127 HYPERGLYCAEMIA 517 0.0192
128 BONE CANCER 51 0.0191
129 BREAST CANCER STAGE IV 19 0.0190
130 THROMBOTIC MICROANGIOPATHY 112 0.0190
131 BONE MARROW TOXICITY 23 0.0189
132 FEEDING DISORDER 202 0.0189
133 INTERSTITIAL LUNG DISEASE 587 0.0183
134 ABSCESS ORAL 18 0.0182
135 EXPOSED BONE IN JAW 36 0.0180
136 ALVEOLITIS 22 0.0179
137 VARICELLA ZOSTER VIRUS INFECTION 22 0.0176
138 HYPERCHOLESTEROLAEMIA 103 0.0174
139 BILE DUCT OBSTRUCTION 33 0.0172
140 PROTEINURIA 206 0.0171
141 DYSLIPIDAEMIA 59 0.0171
142 LIVER ABSCESS 37 0.0170
143 OSTEONECROSIS OF JAW 347 0.0170
144 RENAL MASS 25 0.0170
145 EATING DISORDER 257 0.0170
146 TASTE DISORDER 107 0.0168
147 ORTHOPNOEA 42 0.0166
148 PULMONARY TOXICITY 63 0.0165
149 BLOOD LACTATE DEHYDROGENASE INCREASED 209 0.0165
150 BLOOD PHOSPHORUS DECREASED 38 0.0164
151 ACTINIC KERATOSIS 31 0.0162
152 SUBILEUS 27 0.0161
153 SKIN TOXICITY 50 0.0160
154 ODYNOPHAGIA 63 0.0157
155 RALES 65 0.0156
156 BLOOD TRIGLYCERIDES INCREASED 216 0.0156
157 SOFT TISSUE INFECTION 19 0.0155
158 TONGUE BLISTERING 27 0.0154
159 C-REACTIVE PROTEIN INCREASED 356 0.0152
160 DISEASE PROGRESSION 1073 0.0152
161 BLOOD PRESSURE DIASTOLIC INCREASED 40 0.0151
162 DRUG LEVEL INCREASED 171 0.0150
163 BLOOD PRESSURE DIASTOLIC DECREASED 69 0.0146
164 CHRONIC GRAFT VERSUS HOST DISEASE 35 0.0146
165 NEOPLASM MALIGNANT 637 0.0145
166 GLOMERULAR FILTRATION RATE DECREASED 100 0.0144
167 CYTOMEGALOVIRUS INFECTION 165 0.0144
168 PROTEIN TOTAL DECREASED 40 0.0143
169 PULMONARY MASS 139 0.0143
170 PERICARDIAL EFFUSION 224 0.0143
171 ATYPICAL PNEUMONIA 26 0.0142
172 BLOOD CREATININE ABNORMAL 32 0.0142
173 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 226 0.0141
174 INFUSION SITE HAEMORRHAGE 22 0.0141
175 VASODILATATION 27 0.0141
176 METASTATIC NEOPLASM 41 0.0140
177 GAMMA-GLUTAMYLTRANSFERASE INCREASED 248 0.0140
178 LUNG DISORDER 462 0.0140
179 CHEILITIS 56 0.0138
180 HEPATIC PAIN 42 0.0137
181 URINARY TRACT INFECTION BACTERIAL 22 0.0137
182 HYPERURICAEMIA 40 0.0137
183 INGROWING NAIL 23 0.0136
184 SQUAMOUS CELL CARCINOMA OF SKIN 52 0.0135
185 LYMPHOCYTE COUNT DECREASED 161 0.0132
186 EPSTEIN-BARR VIRUS INFECTION 56 0.0132
187 DRUG LEVEL BELOW THERAPEUTIC 41 0.0132
188 LUNG NEOPLASM 47 0.0132
189 BLOOD CHOLESTEROL INCREASED 426 0.0131
190 GENERAL PHYSICAL HEALTH DETERIORATION 920 0.0131
191 SPINAL PAIN 99 0.0130
192 BLOOD CREATININE INCREASED 626 0.0129
193 TUMOUR HAEMORRHAGE 25 0.0129
194 ORGANISING PNEUMONIA 38 0.0129
195 GINGIVAL SWELLING 43 0.0129
196 ENTERITIS 50 0.0126
197 EPISTAXIS 691 0.0125
198 HYPOPHAGIA 216 0.0125
199 GLOSSODYNIA 159 0.0124
200 ATELECTASIS 93 0.0123
201 RED CELL DISTRIBUTION WIDTH INCREASED 31 0.0122
202 GINGIVAL PAIN 70 0.0122
203 RENAL TUBULAR NECROSIS 86 0.0121
204 ORAL DISORDER 64 0.0121
205 MOUTH SWELLING 45 0.0120
206 URINE OUTPUT DECREASED 82 0.0120
207 BLOOD ALBUMIN DECREASED 71 0.0119
208 ESCHERICHIA URINARY TRACT INFECTION 37 0.0119
209 ESCHERICHIA SEPSIS 25 0.0118
210 ABDOMINAL MASS 21 0.0117
211 DECREASED APPETITE 1769 0.0116
212 PARONYCHIA 32 0.0115
213 HYPERCALCAEMIA 100 0.0115
214 CHAPPED LIPS 36 0.0114
215 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 27 0.0113
216 BONE MARROW DISORDER 23 0.0113
217 BLOOD UREA INCREASED 153 0.0111
218 OSTEITIS 22 0.0111
219 BLOOD ALKALINE PHOSPHATASE INCREASED 222 0.0111
220 NEPHROTIC SYNDROME 53 0.0110
221 COVID-19 PNEUMONIA 41 0.0110
222 PORTAL HYPERTENSION 24 0.0110
223 DECREASED IMMUNE RESPONSIVENESS 60 0.0109
224 BOWEL MOVEMENT IRREGULARITY 49 0.0109
225 BLOOD MAGNESIUM DECREASED 62 0.0109
226 AZOTAEMIA 31 0.0109
227 ENTEROCOCCAL INFECTION 35 0.0109
228 TYPE I HYPERSENSITIVITY 20 0.0108
229 TONGUE OEDEMA 31 0.0107
230 TONGUE DISCOMFORT 26 0.0107
231 TERMINAL STATE 52 0.0107
232 HAEMOLYTIC URAEMIC SYNDROME 21 0.0107
233 POLYNEUROPATHY 79 0.0106
234 GENERALISED OEDEMA 90 0.0106
235 LIP PAIN 22 0.0106
236 ORAL HERPES 128 0.0106
237 CHOLECYSTITIS INFECTIVE 20 0.0106
238 HYDRONEPHROSIS 56 0.0105
239 FIBRIN D DIMER INCREASED 25 0.0105
240 ABDOMINAL HERNIA 36 0.0105
241 PROTEIN URINE PRESENT 36 0.0104
242 STEATORRHOEA 23 0.0104
243 NEOPLASM RECURRENCE 24 0.0104
244 GLOSSITIS 27 0.0102
245 FOOD INTOLERANCE 24 0.0102
246 PERFORMANCE STATUS DECREASED 36 0.0102
247 DERMATITIS ACNEIFORM 41 0.0102
248 HORDEOLUM 21 0.0102
249 FOLLICULITIS 34 0.0101
250 PNEUMOTHORAX 109 0.0101
251 BRAIN NEOPLASM 62 0.0100
252 NEPHROPATHY TOXIC 70 0.0100
253 RENAL IMPAIRMENT 546 0.0099
254 ELECTROLYTE IMBALANCE 76 0.0098
255 HAEMOGLOBIN DECREASED 731 0.0097
256 SKIN HYPERTROPHY 19 0.0097
257 MUSCULOSKELETAL CHEST PAIN 106 0.0097
258 PNEUMONIA BACTERIAL 47 0.0096
259 THERAPY CHANGE 49 0.0096
260 NECK MASS 19 0.0096
261 GINGIVITIS 38 0.0096
262 DEATH 5421 0.0094
263 MULTIPLE ORGAN DYSFUNCTION SYNDROME 141 0.0094
264 HYPERLIPIDAEMIA 90 0.0093
265 ACUTE LYMPHOCYTIC LEUKAEMIA 19 0.0093
266 COUGH 1687 0.0093
267 NEEDLE ISSUE 122 0.0093
268 ESCHERICHIA INFECTION 49 0.0092
269 HYPOALBUMINAEMIA 47 0.0092
270 PIGMENTATION DISORDER 38 0.0092
271 LYMPHOPENIA 84 0.0091
272 BLOOD URIC ACID INCREASED 35 0.0091
273 KLEBSIELLA INFECTION 29 0.0091
274 TOOTHACHE 117 0.0091
275 ERYSIPELAS 33 0.0090
276 SPINAL CORD COMPRESSION 26 0.0090
277 MALNUTRITION 68 0.0090
278 DEHYDRATION 885 0.0090
279 POLYURIA 52 0.0090
280 BLOOD CALCIUM DECREASED 74 0.0089
281 OEDEMA PERIPHERAL 868 0.0089
282 SKIN MASS 37 0.0088
283 BLOOD CREATINE INCREASED 27 0.0088
284 ANAEMIA 1214 0.0087
285 PLATELET COUNT DECREASED 628 0.0087
286 YELLOW SKIN 31 0.0087
287 DIASTOLIC DYSFUNCTION 19 0.0087
288 ORAL DISCOMFORT 88 0.0086
289 HAEMATOCRIT DECREASED 137 0.0086
290 OEDEMA 325 0.0086
291 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 25 0.0085
292 APHAGIA 41 0.0085
293 LUNG INFECTION 133 0.0085
294 RED BLOOD CELL COUNT DECREASED 163 0.0085
295 LEFT VENTRICULAR FAILURE 21 0.0084
296 FLUID INTAKE REDUCED 27 0.0084
297 EJECTION FRACTION DECREASED 89 0.0084
298 VEIN DISORDER 31 0.0083
299 PULMONARY OEDEMA 272 0.0083
300 UROSEPSIS 53 0.0083
301 HOSPICE CARE 42 0.0083
302 WEIGHT DECREASED 1596 0.0083
303 PROCTALGIA 37 0.0083
304 HAEMATOTOXICITY 44 0.0082
305 JAUNDICE CHOLESTATIC 22 0.0082
306 BLOOD CALCIUM INCREASED 54 0.0082
307 LEFT VENTRICULAR DYSFUNCTION 39 0.0082
308 CHOLECYSTITIS 71 0.0082
309 GENERAL PHYSICAL CONDITION ABNORMAL 36 0.0081
310 LYMPHADENOPATHY 202 0.0081
311 PAPULE 32 0.0081
312 RENAL CYST 49 0.0081
313 FLANK PAIN 54 0.0081
314 HYPOCALCAEMIA 106 0.0081
315 WOUND DEHISCENCE 21 0.0080
316 BREAST CANCER 578 0.0080
317 FAILURE TO THRIVE 33 0.0080
318 BONE PAIN 339 0.0080
319 DYSGEUSIA 428 0.0080
320 THROMBOCYTOPENIA 607 0.0079
321 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 48 0.0079
322 LOOSE TOOTH 20 0.0079
323 HYPOXIA 189 0.0079
324 PERIPHERAL SWELLING 749 0.0078
325 FURUNCLE 45 0.0078
326 MASS 81 0.0078
327 HYPOMAGNESAEMIA 69 0.0078
328 NASAL DRYNESS 34 0.0077
329 BLOOD POTASSIUM INCREASED 92 0.0077
330 HEPATOMEGALY 60 0.0077
331 BLOOD PRESSURE INCREASED 824 0.0077
332 DIARRHOEA 3258 0.0077
333 PARTIAL SEIZURES 27 0.0077
334 PYREXIA 1866 0.0076
335 AGEUSIA 134 0.0076
336 ACUTE PULMONARY OEDEMA 33 0.0076
337 SMALL INTESTINAL OBSTRUCTION 66 0.0076
338 GASTROENTERITIS VIRAL 90 0.0076
339 BREATH SOUNDS ABNORMAL 24 0.0076
340 BLOOD IRON DECREASED 53 0.0076
341 PATHOLOGICAL FRACTURE 28 0.0076
342 ASPHYXIA 41 0.0075
343 TRICUSPID VALVE INCOMPETENCE 43 0.0075
344 APPETITE DISORDER 30 0.0075
345 BLOOD POTASSIUM DECREASED 161 0.0074
346 SKIN LESION 136 0.0074
347 NECROSIS 32 0.0074
348 SEIZURE 515 0.0074
349 BRONCHOPULMONARY ASPERGILLOSIS 36 0.0074
350 PANCREATIC DISORDER 24 0.0073
351 NAIL DISCOLOURATION 20 0.0073
352 ACUTE RESPIRATORY DISTRESS SYNDROME 92 0.0073
353 NODULE 64 0.0073
354 PLATELET COUNT INCREASED 64 0.0073
355 TENDERNESS 55 0.0072
356 LEUKOPENIA 253 0.0072
357 RENAL FUNCTION TEST ABNORMAL 20 0.0071
358 IMPAIRED HEALING 156 0.0071
359 HYPOKALAEMIA 227 0.0071
360 ILEUS 62 0.0071
361 PRODUCTIVE COUGH 209 0.0071
362 INTESTINAL OBSTRUCTION 173 0.0070
363 PULMONARY ALVEOLAR HAEMORRHAGE 25 0.0070
364 INFLAMMATION 215 0.0070
365 PULMONARY CONGESTION 66 0.0070
366 DYSPNOEA EXERTIONAL 169 0.0069
367 ASPARTATE AMINOTRANSFERASE INCREASED 279 0.0069
368 ACNE 415 0.0069
369 BLOOD URINE PRESENT 98 0.0069
370 DRUG INTOLERANCE 413 0.0069
371 CONGESTIVE CARDIOMYOPATHY 26 0.0069
372 CANDIDA INFECTION 70 0.0069
373 RESPIRATORY FAILURE 372 0.0068
374 HEPATIC ENZYME ABNORMAL 23 0.0068
375 HEPATIC FAILURE 157 0.0068
376 DIFFUSE LARGE B-CELL LYMPHOMA 27 0.0068
377 LIP DRY 31 0.0068
378 GASTROINTESTINAL PERFORATION 20 0.0068
379 AORTIC VALVE INCOMPETENCE 22 0.0068
380 PRODUCT USE IN UNAPPROVED INDICATION 805 0.0067
381 APPARENT DEATH 24 0.0067
382 HEPATIC FUNCTION ABNORMAL 163 0.0067
383 HYDROCEPHALUS 27 0.0067
384 HYPERKERATOSIS 26 0.0067
385 ANAL INCONTINENCE 32 0.0067
386 GASTRITIS 126 0.0065
387 ABDOMINAL ABSCESS 20 0.0065
388 LARGE INTESTINE PERFORATION 33 0.0065
389 LOCALISED OEDEMA 23 0.0065
390 DIABETES MELLITUS 374 0.0065
391 SEPTIC SHOCK 187 0.0064
392 GASTROENTERITIS 68 0.0064
393 NEUTROPHIL COUNT DECREASED 158 0.0064
394 RENAL DISORDER 211 0.0064
395 CARDIAC FAILURE ACUTE 27 0.0064
396 LIVER FUNCTION TEST INCREASED 77 0.0064
397 PYELONEPHRITIS 38 0.0064
398 OVARIAN CYST 51 0.0064
399 OESOPHAGITIS 51 0.0064
400 NEUTROPHIL COUNT INCREASED 48 0.0064
401 SKIN ULCER 118 0.0064
402 ULCER 71 0.0062
403 RENAL PAIN 46 0.0062
404 BODY TEMPERATURE INCREASED 94 0.0062
405 BREAST MASS 30 0.0062
406 IMMUNODEFICIENCY 49 0.0062
407 ACUTE RESPIRATORY FAILURE 75 0.0061
408 BLOOD SODIUM DECREASED 82 0.0061
409 FACIAL PARALYSIS 33 0.0061
410 LOW DENSITY LIPOPROTEIN INCREASED 32 0.0061
411 VITAMIN D DECREASED 38 0.0061
412 GROIN PAIN 40 0.0061
413 PNEUMONIA 1338 0.0061
414 FATIGUE 3144 0.0061
415 RASH 1721 0.0060
416 ASTHENIA 1595 0.0060
417 INTESTINAL PERFORATION 48 0.0060
418 FAECES DISCOLOURED 96 0.0060
419 INCONTINENCE 46 0.0060
420 DERMATITIS 78 0.0059
421 FAECALOMA 22 0.0059
422 ASPERGILLUS INFECTION 21 0.0059
423 BONE MARROW FAILURE 106 0.0059
424 PHLEBITIS 24 0.0059
425 ABDOMINAL PAIN 960 0.0059
426 SKIN DISORDER 123 0.0059
427 RESPIRATORY RATE INCREASED 37 0.0059
428 TOOTH ABSCESS 46 0.0059
429 THERAPY INTERRUPTED 67 0.0058
430 STREPTOCOCCAL INFECTION 21 0.0058
431 PURULENT DISCHARGE 19 0.0058
432 CHOLELITHIASIS 143 0.0058
433 LIVER DISORDER 174 0.0058
434 METABOLIC DISORDER 25 0.0058
435 THERAPY CESSATION 189 0.0057
436 NEUTROPENIA 462 0.0057
437 CARDIOMEGALY 59 0.0057
438 DYSURIA 156 0.0057
439 ALANINE AMINOTRANSFERASE INCREASED 266 0.0057
440 OLIGURIA 27 0.0057
441 APHONIA 52 0.0057
442 TRANSAMINASES INCREASED 93 0.0057
443 DYSPNOEA 2278 0.0057
444 BLISTER 209 0.0057
445 EYELID OEDEMA 56 0.0056
446 ENTEROCOLITIS 19 0.0056
447 HEPATOCELLULAR CARCINOMA 31 0.0056
448 SQUAMOUS CELL CARCINOMA 38 0.0056
449 EAR INFECTION 91 0.0056
450 ABNORMAL FAECES 30 0.0056
451 MITRAL VALVE INCOMPETENCE 48 0.0056
452 TOOTH INFECTION 49 0.0056
453 EMBOLISM 35 0.0056
454 BLOOD GLUCOSE ABNORMAL 72 0.0055
455 WOUND 85 0.0055
456 PHARYNGITIS STREPTOCOCCAL 38 0.0055
457 CARDIAC FAILURE 312 0.0055
458 ANURIA 38 0.0055
459 OROPHARYNGEAL PAIN 340 0.0055
460 DUODENAL ULCER 29 0.0055
461 THYROID FUNCTION TEST ABNORMAL 19 0.0055
462 RETINAL DETACHMENT 35 0.0055
463 WOUND INFECTION 34 0.0054
464 LIVER FUNCTION TEST ABNORMAL 135 0.0054
465 HAEMOPTYSIS 114 0.0054
466 PERIPHERAL SENSORY NEUROPATHY 21 0.0054
467 MOUTH HAEMORRHAGE 28 0.0054
468 BLOOD THYROID STIMULATING HORMONE INCREASED 37 0.0054
469 PANCYTOPENIA 208 0.0054
470 LIPASE INCREASED 31 0.0054
471 WHITE BLOOD CELL COUNT DECREASED 390 0.0054
472 VIRAL INFECTION 119 0.0054
473 GASTROINTESTINAL MOTILITY DISORDER 19 0.0054
474 ABDOMINAL DISTENSION 386 0.0054
475 CHOLECYSTITIS ACUTE 23 0.0054
476 FEBRILE NEUTROPENIA 225 0.0053
477 FLATULENCE 211 0.0053
478 MELAENA 89 0.0053
479 DRY MOUTH 301 0.0053
480 CHOLESTASIS 70 0.0053
481 GLUCOSE TOLERANCE IMPAIRED 21 0.0053
482 STATUS EPILEPTICUS 43 0.0053
483 ABDOMINAL TENDERNESS 20 0.0053
484 DYSPHONIA 211 0.0053
485 HYPOTHYROIDISM 108 0.0053
486 CYTOPENIA 27 0.0053
487 ENCEPHALITIS 24 0.0052
488 PULMONARY FIBROSIS 64 0.0052
489 BACTERIAL INFECTION 62 0.0052
490 MALAISE 1680 0.0052
491 BASAL CELL CARCINOMA 56 0.0051
492 IRON DEFICIENCY ANAEMIA 34 0.0051
493 RENAL FAILURE 550 0.0051
494 JAUNDICE 111 0.0051
495 PERIPHERAL COLDNESS 51 0.0051
496 RESPIRATORY DISTRESS 106 0.0051
497 VOMITING 1671 0.0051
498 TYPE 1 DIABETES MELLITUS 20 0.0051
499 GENERALISED TONIC-CLONIC SEIZURE 52 0.0051
500 RHINITIS 28 0.0051
501 HAEMORRHOIDS 73 0.0051
502 SECRETION DISCHARGE 37 0.0051
503 HYPERTENSION 740 0.0050
504 SPUTUM DISCOLOURED 32 0.0050
505 DYSPHAGIA 332 0.0050
506 BLOOD BILIRUBIN INCREASED 105 0.0050
507 CARDIOMYOPATHY 56 0.0050
508 HYPOVOLAEMIA 22 0.0050
509 FULL BLOOD COUNT DECREASED 62 0.0050
510 GINGIVAL BLEEDING 46 0.0050
511 CONSTIPATION 700 0.0050
512 TONGUE DISORDER 29 0.0050
513 HEPATOTOXICITY 71 0.0049
514 PAIN IN JAW 107 0.0049
515 URINARY TRACT INFECTION 559 0.0049
516 SWOLLEN TONGUE 117 0.0049
517 ORAL CANDIDIASIS 43 0.0049
518 MULTI-ORGAN FAILURE 85 0.0049
519 ANGIOEDEMA 152 0.0049
520 RESPIRATORY TRACT INFECTION 81 0.0049
521 BLOOD PRESSURE ABNORMAL 59 0.0048
522 GASTRIC HAEMORRHAGE 45 0.0048
523 TACHYPNOEA 43 0.0048
524 BLOOD GLUCOSE INCREASED 695 0.0048
525 CLOSTRIDIUM DIFFICILE COLITIS 36 0.0048
526 BREAST PAIN 40 0.0048
527 BRAIN OEDEMA 44 0.0048
528 PSEUDOMONAS INFECTION 26 0.0048
529 HYPERTHERMIA 27 0.0048
530 EAR PAIN 64 0.0048
531 GRAFT VERSUS HOST DISEASE 26 0.0048
532 ABDOMINAL PAIN UPPER 675 0.0048
533 SKIN PLAQUE 25 0.0048
534 SPINAL COMPRESSION FRACTURE 31 0.0048
535 EPILEPSY 95 0.0047
536 SINUS TACHYCARDIA 50 0.0047
537 FACE OEDEMA 60 0.0047
538 MUSCULOSKELETAL PAIN 214 0.0047
539 LETHARGY 201 0.0046
540 INFECTION 427 0.0046
541 SEPSIS 371 0.0046
542 ABSCESS 50 0.0046
543 FACIAL PAIN 28 0.0046
544 GASTROINTESTINAL INFECTION 27 0.0046
545 PHARYNGITIS 42 0.0046
546 HEPATOCELLULAR INJURY 56 0.0046
547 RHINORRHOEA 188 0.0046
548 HEPATIC ENCEPHALOPATHY 32 0.0046
549 RASH PUSTULAR 28 0.0046
550 ACUTE KIDNEY INJURY 445 0.0046
551 COLITIS 105 0.0045
552 HEPATIC ENZYME INCREASED 197 0.0045
553 HYPERTENSIVE CRISIS 37 0.0045
554 HYPERKALAEMIA 112 0.0045
555 RESPIRATORY DISORDER 95 0.0045
556 ILLNESS 84 0.0044
557 IMPAIRED GASTRIC EMPTYING 23 0.0044
558 GOUT 55 0.0044
559 LIP SWELLING 104 0.0044
560 FREQUENT BOWEL MOVEMENTS 66 0.0044
561 ACIDOSIS 25 0.0043
562 HAEMOLYSIS 25 0.0043
563 PALLOR 79 0.0043
564 BONE DISORDER 63 0.0043
565 ATAXIA 39 0.0043
566 TOOTH DISORDER 71 0.0043
567 CARDIAC VALVE DISEASE 19 0.0043
568 HEPATITIS 78 0.0043
569 CENTRAL NERVOUS SYSTEM LESION 48 0.0042
570 ARTERIOSCLEROSIS 30 0.0042
571 SWELLING 258 0.0042
572 FLUID RETENTION 156 0.0042
573 POOR VENOUS ACCESS 23 0.0042
574 BACK PAIN 691 0.0042
575 HERPES SIMPLEX 19 0.0041
576 INFLUENZA 292 0.0041
577 HYPOKINESIA 44 0.0041
578 DRUG RESISTANCE 67 0.0041
579 PULMONARY EMBOLISM 307 0.0041
580 DRY SKIN 347 0.0041
581 RASH GENERALISED 106 0.0041
582 NAUSEA 2254 0.0041
583 ABNORMAL BEHAVIOUR 136 0.0041
584 THIRST 47 0.0041
585 ADRENAL INSUFFICIENCY 26 0.0040
586 METABOLIC ACIDOSIS 85 0.0040
587 HERNIA 51 0.0040
588 HEPATIC STEATOSIS 53 0.0040
589 COVID-19 134 0.0040
590 HYPOACUSIS 105 0.0040
591 HAEMATURIA 106 0.0040
592 RENAL FAILURE ACUTE 169 0.0040
593 DENTAL CARIES 33 0.0040
594 PLEURISY 19 0.0040
595 HYPONATRAEMIA 163 0.0040
596 BLOOD PRESSURE DECREASED 187 0.0040
597 CELLULITIS 147 0.0039
598 MENSTRUAL DISORDER 24 0.0039
599 HAEMATEMESIS 76 0.0039
600 BLOOD GLUCOSE FLUCTUATION 33 0.0039
601 ARTHROPOD BITE 20 0.0039
602 NASOPHARYNGITIS 467 0.0039
603 HEPATIC CIRRHOSIS 49 0.0039
604 HEART RATE DECREASED 95 0.0039
605 GASTROINTESTINAL PAIN 28 0.0039
606 BLOOD TEST ABNORMAL 33 0.0039
607 DRUG INTERACTION 455 0.0039
608 SWELLING FACE 184 0.0039
609 FISTULA 28 0.0039
610 BLOOD PRESSURE FLUCTUATION 65 0.0039
611 SKIN INFECTION 28 0.0039
612 FEELING COLD 78 0.0039
613 LIGAMENT SPRAIN 25 0.0039
614 TUBULOINTERSTITIAL NEPHRITIS 50 0.0039
615 RENAL CANCER 138 0.0039
616 DIABETES MELLITUS INADEQUATE CONTROL 50 0.0038
617 GASTRIC ULCER 56 0.0038
618 CLOSTRIDIUM DIFFICILE INFECTION 53 0.0038
619 NIGHT SWEATS 82 0.0038
620 MOVEMENT DISORDER 90 0.0038
621 BLOOD COUNT ABNORMAL 65 0.0038
622 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23 0.0038
623 TOXICITY TO VARIOUS AGENTS 426 0.0038
624 APPENDICITIS 23 0.0038
625 CHOKING 51 0.0038
626 SKIN DISCOLOURATION 126 0.0038
627 RASH PRURITIC 137 0.0038
628 CYSTITIS 90 0.0038
629 CHILLS 313 0.0038
630 CONJUNCTIVITIS 40 0.0038
631 SUDDEN DEATH 33 0.0038
632 UPPER RESPIRATORY TRACT INFECTION 120 0.0038
633 NEPHROPATHY 27 0.0038
634 EYE INFECTION 26 0.0037
635 ABDOMINAL DISCOMFORT 410 0.0037
636 ECCHYMOSIS 20 0.0037
637 ENCEPHALOPATHY 62 0.0037
638 PRURITUS GENERALISED 80 0.0037
639 RETCHING 55 0.0037
640 POLLAKIURIA 109 0.0037
641 HEPATIC CANCER 59 0.0037
642 HYPOGLYCAEMIA 134 0.0036
643 SHOCK HAEMORRHAGIC 20 0.0036
644 WHITE BLOOD CELL COUNT INCREASED 105 0.0036
645 BACTERAEMIA 27 0.0036
646 JOINT SWELLING 276 0.0036
647 NERVE COMPRESSION 23 0.0036
648 DECUBITUS ULCER 22 0.0036
649 TOXIC SKIN ERUPTION 26 0.0036
650 SPEECH DISORDER 139 0.0036
651 HEPATITIS C 38 0.0035
652 SCRATCH 20 0.0035
653 HYPERBILIRUBINAEMIA 25 0.0035
654 RIB FRACTURE 51 0.0035
655 ABDOMINAL PAIN LOWER 66 0.0035
656 LOCAL SWELLING 61 0.0035
657 LEUKOCYTOSIS 45 0.0035
658 TUBERCULOSIS 31 0.0035
659 GALLBLADDER DISORDER 49 0.0035
660 CIRCULATORY COLLAPSE 47 0.0035
661 SPINAL OSTEOARTHRITIS 23 0.0034
662 EOSINOPHIL COUNT INCREASED 19 0.0034
663 PULMONARY HAEMORRHAGE 21 0.0034
664 GLYCOSYLATED HAEMOGLOBIN INCREASED 57 0.0034
665 DISSEMINATED INTRAVASCULAR COAGULATION 38 0.0034
666 OSTEOMYELITIS 48 0.0034
667 DECREASED ACTIVITY 22 0.0034
668 NEUROPATHY PERIPHERAL 201 0.0033
669 GAIT INABILITY 53 0.0033
670 SCAB 26 0.0033
671 THYROID DISORDER 35 0.0033
672 PNEUMONIA ASPIRATION 58 0.0033
673 EYE SWELLING 86 0.0033
674 RIGHT VENTRICULAR FAILURE 19 0.0033
675 CHEST PAIN 461 0.0033
676 STAPHYLOCOCCAL INFECTION 84 0.0033
677 THROMBOSIS 193 0.0033
678 PRURITUS 743 0.0033
679 INJECTION SITE MASS 78 0.0033
680 PAIN 1300 0.0033
681 WHEEZING 120 0.0032
682 DRY THROAT 23 0.0032
683 NASAL CONGESTION 117 0.0032
684 SUBARACHNOID HAEMORRHAGE 24 0.0032
685 HYPERSOMNIA 65 0.0032
686 JOINT INJURY 47 0.0032
687 NEUROTOXICITY 34 0.0032
688 HEMIPARESIS 43 0.0032
689 HYPERTHYROIDISM 31 0.0032
690 DIVERTICULUM 20 0.0032
691 SNEEZING 45 0.0032
692 IMMUNE SYSTEM DISORDER 28 0.0032
693 INTERNAL HAEMORRHAGE 27 0.0032
694 HERPES ZOSTER 128 0.0032
695 SKIN EXFOLIATION 173 0.0032
696 THERAPY NON-RESPONDER 70 0.0032
697 ERUCTATION 36 0.0032
698 DEVICE RELATED INFECTION 38 0.0032
699 SKIN FISSURES 29 0.0031
700 UPPER GASTROINTESTINAL HAEMORRHAGE 41 0.0031
701 OVARIAN CANCER 21 0.0031
702 PAIN IN EXTREMITY 675 0.0031
703 HEART RATE IRREGULAR 55 0.0031
704 NO THERAPEUTIC RESPONSE 38 0.0031
705 LIVER INJURY 37 0.0031
706 DYSSTASIA 65 0.0031
707 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 202 0.0031
708 CONTUSION 205 0.0031
709 APHASIA 69 0.0031
710 HAEMATOMA 62 0.0031
711 LOCALISED INFECTION 51 0.0031
712 BURSITIS 22 0.0031
713 MUSCULOSKELETAL DISCOMFORT 36 0.0031
714 MYOCLONUS 27 0.0030
715 MENTAL STATUS CHANGES 64 0.0030
716 MICTURITION URGENCY 24 0.0030
717 SEASONAL ALLERGY 23 0.0030
718 LOWER RESPIRATORY TRACT INFECTION 83 0.0030
719 CONFUSIONAL STATE 352 0.0030
720 HEMIPLEGIA 19 0.0030
721 HYPERAESTHESIA 19 0.0030
722 SKIN CANCER 39 0.0030
723 FUNGAL INFECTION 68 0.0030
724 CYANOSIS 35 0.0029
725 AMENORRHOEA 38 0.0029
726 KIDNEY INFECTION 39 0.0029
727 HYPOAESTHESIA ORAL 32 0.0029
728 COMPLICATION ASSOCIATED WITH DEVICE 25 0.0029
729 SUPRAVENTRICULAR TACHYCARDIA 21 0.0029
730 COAGULOPATHY 37 0.0029
731 BLOOD GLUCOSE DECREASED 108 0.0029
732 ARTHRALGIA 757 0.0029
733 DISORIENTATION 89 0.0028
734 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0028
735 GASTROINTESTINAL DISORDER 141 0.0028
736 SINUSITIS 196 0.0028
737 PULMONARY HYPERTENSION 45 0.0028
738 RESPIRATORY ARREST 66 0.0028
739 CARDIAC MURMUR 20 0.0028
740 SPINAL DISORDER 19 0.0028
741 DISCOMFORT 96 0.0028
742 HYPOTENSION 395 0.0028
743 PRODUCT USE ISSUE 328 0.0028
744 HAEMOLYTIC ANAEMIA 19 0.0028
745 HAEMATOCHEZIA 95 0.0028
746 NOCTURIA 22 0.0028
747 POOR QUALITY SLEEP 39 0.0027
748 PARALYSIS 29 0.0027
749 OXYGEN SATURATION DECREASED 93 0.0027
750 DEEP VEIN THROMBOSIS 146 0.0027
751 SKIN REACTION 27 0.0027
752 ACUTE CORONARY SYNDROME 18 0.0027
753 SCIATICA 26 0.0027
754 BRONCHITIS 151 0.0027
755 THERAPEUTIC RESPONSE DECREASED 110 0.0027
756 PELVIC PAIN 37 0.0027
757 ERYTHEMA 399 0.0027
758 CEREBRAL HAEMORRHAGE 72 0.0027
759 ASPIRATION 20 0.0027
760 PERITONITIS 43 0.0027
761 MALIGNANT MELANOMA 26 0.0027
762 MOOD ALTERED 53 0.0027
763 CYST 23 0.0026
764 NEPHROLITHIASIS 80 0.0026
765 TYPE 2 DIABETES MELLITUS 65 0.0026
766 ECZEMA 47 0.0026
767 HEART RATE INCREASED 183 0.0026
768 DELIRIUM 61 0.0026
769 SINUS CONGESTION 25 0.0026
770 EMPHYSEMA 20 0.0026
771 HEADACHE 1141 0.0026
772 CHEST DISCOMFORT 178 0.0026
773 PARAESTHESIA ORAL 25 0.0025
774 FLUSHING 204 0.0025
775 PHARYNGEAL OEDEMA 38 0.0025
776 TACHYCARDIA 159 0.0025
777 MYALGIA 310 0.0025
778 GASTROINTESTINAL HAEMORRHAGE 174 0.0025
779 NECK PAIN 98 0.0025
780 RENAL FAILURE CHRONIC 19 0.0025
781 LIMB DISCOMFORT 51 0.0025
782 SLEEP DISORDER 108 0.0025
783 GAIT DISTURBANCE 341 0.0025
784 BLOOD CREATINE PHOSPHOKINASE INCREASED 57 0.0024
785 LUNG NEOPLASM MALIGNANT 72 0.0024
786 URINARY INCONTINENCE 53 0.0024
787 DYSPEPSIA 165 0.0024
788 TREATMENT FAILURE 123 0.0024
789 CHROMATURIA 41 0.0024
790 HOT FLUSH 114 0.0024
791 BREAST CANCER FEMALE 41 0.0024
792 ILL-DEFINED DISORDER 66 0.0024
793 HAEMORRHAGE 171 0.0024
794 URINARY RETENTION 56 0.0024
795 EYE DISORDER 52 0.0023
796 ARRHYTHMIA 84 0.0023
797 WRIST FRACTURE 20 0.0023
798 ACUTE HEPATIC FAILURE 21 0.0023
799 UPPER LIMB FRACTURE 35 0.0023
800 LOWER LIMB FRACTURE 28 0.0023
801 DEPRESSED MOOD 83 0.0023
802 INCREASED APPETITE 27 0.0023
803 ACUTE MYOCARDIAL INFARCTION 54 0.0023
804 LACRIMATION INCREASED 42 0.0023
805 NERVOUSNESS 96 0.0023
806 STRESS 108 0.0023
807 LIMB INJURY 39 0.0023
808 ALTERED STATE OF CONSCIOUSNESS 32 0.0023
809 SYNCOPE 167 0.0023
810 INJECTION SITE INDURATION 23 0.0023
811 SCAR 29 0.0023
812 ALOPECIA 322 0.0022
813 AGGRESSION 89 0.0022
814 MUSCULAR WEAKNESS 183 0.0022
815 ATRIAL FIBRILLATION 153 0.0022
816 CARDIO-RESPIRATORY ARREST 74 0.0022
817 CEREBRAL INFARCTION 41 0.0022
818 INSOMNIA 434 0.0022
819 RECTAL HAEMORRHAGE 71 0.0022
820 DIZZINESS 776 0.0022
821 PRODUCT DISPENSING ERROR 20 0.0022
822 DEAFNESS 39 0.0022
823 SPINAL FRACTURE 29 0.0022
824 LABORATORY TEST ABNORMAL 44 0.0022
825 PANCREATITIS 86 0.0022
826 MENSTRUATION IRREGULAR 49 0.0022
827 BURNING SENSATION 110 0.0021
828 ABASIA 53 0.0021
829 MYELODYSPLASTIC SYNDROME 23 0.0021
830 NEURALGIA 34 0.0021
831 COMA 74 0.0021
832 PANCREATITIS ACUTE 33 0.0021
833 PRODUCT DOSE OMISSION ISSUE 125 0.0021
834 FRACTURE 29 0.0021
835 DIVERTICULITIS 40 0.0021
836 DRY EYE 52 0.0021
837 OSTEOPENIA 22 0.0021
838 HIP FRACTURE 46 0.0021
839 HEAD DISCOMFORT 23 0.0021
840 ACUTE MYELOID LEUKAEMIA 22 0.0021
841 ROAD TRAFFIC ACCIDENT 62 0.0020
842 FLUID OVERLOAD 30 0.0020
843 HEAD INJURY 45 0.0020
844 FALL 476 0.0020
845 FEMUR FRACTURE 50 0.0020
846 DISEASE RECURRENCE 33 0.0020
847 HYPOAESTHESIA 217 0.0020
848 CATARACT 77 0.0020
849 SINUS DISORDER 27 0.0020
850 OCULAR HYPERAEMIA 57 0.0020
851 ANGINA PECTORIS 45 0.0020
852 FEELING ABNORMAL 355 0.0020
853 DRUG-INDUCED LIVER INJURY 31 0.0020
854 URTICARIA 220 0.0020
855 EOSINOPHILIA 23 0.0020
856 LOSS OF CONSCIOUSNESS 185 0.0019
857 HYPERSENSITIVITY 252 0.0019
858 CARDIAC FAILURE CONGESTIVE 137 0.0019
859 OFF LABEL USE 842 0.0019
860 RASH ERYTHEMATOUS 56 0.0019
861 MEMORY IMPAIRMENT 187 0.0019
862 RASH MACULO-PAPULAR 29 0.0019
863 GASTROOESOPHAGEAL REFLUX DISEASE 108 0.0019
864 FEELING HOT 82 0.0019
865 OSTEOPOROSIS 56 0.0019
866 INFLUENZA LIKE ILLNESS 122 0.0019
867 ELECTROCARDIOGRAM QT PROLONGED 47 0.0019
868 PARAESTHESIA 215 0.0019
869 DRUG ERUPTION 22 0.0019
870 HIATUS HERNIA 19 0.0019
871 RESPIRATORY TRACT CONGESTION 20 0.0019
872 NERVOUS SYSTEM DISORDER 47 0.0018
873 RASH PAPULAR 32 0.0018
874 DIABETIC KETOACIDOSIS 32 0.0018
875 DEMENTIA 32 0.0018
876 THROAT IRRITATION 54 0.0018
877 SOMNOLENCE 259 0.0018
878 ANKLE FRACTURE 20 0.0018
879 OSTEOARTHRITIS 52 0.0018
880 MIGRAINE 110 0.0018
881 DIPLOPIA 32 0.0018
882 RHABDOMYOLYSIS 54 0.0018
883 TREMOR 218 0.0018
884 CARDIAC DISORDER 122 0.0017
885 BRONCHOSPASM 19 0.0017
886 MUSCLE SPASMS 231 0.0017
887 ANOSMIA 18 0.0017
888 AMNESIA 85 0.0017
889 DEPRESSED LEVEL OF CONSCIOUSNESS 48 0.0017
890 WEIGHT INCREASED 258 0.0017
891 CARDIAC ARREST 105 0.0017
892 GASTRIC DISORDER 50 0.0017
893 CONVULSION 93 0.0016
894 DRUG INEFFECTIVE 1443 0.0016
895 RASH MACULAR 37 0.0016
896 HOSPITALISATION 141 0.0016
897 TOOTH LOSS 24 0.0016
898 INTERNATIONAL NORMALISED RATIO INCREASED 41 0.0016
899 MENORRHAGIA 31 0.0016
900 CHRONIC KIDNEY DISEASE 97 0.0015
901 COLD SWEAT 20 0.0015
902 COGNITIVE DISORDER 49 0.0015
903 GLAUCOMA 21 0.0015
904 OSTEONECROSIS 41 0.0015
905 UNRESPONSIVE TO STIMULI 28 0.0015
906 ANXIETY 312 0.0015
907 PALPITATIONS 125 0.0015
908 BLINDNESS 41 0.0015
909 PSYCHOTIC DISORDER 32 0.0015
910 PANCREATIC CARCINOMA 29 0.0014
911 POST PROCEDURAL COMPLICATION 21 0.0014
912 MOBILITY DECREASED 69 0.0014
913 CRYING 42 0.0014
914 IRRITABILITY 67 0.0014
915 ISCHAEMIC STROKE 19 0.0014
916 EYE PRURITUS 25 0.0014
917 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 99 0.0014
918 CEREBROVASCULAR ACCIDENT 184 0.0014
919 DYSARTHRIA 39 0.0014
920 FOOT FRACTURE 19 0.0014
921 ASTHMA 91 0.0014
922 MEDICATION ERROR 56 0.0014
923 JOINT STIFFNESS 25 0.0014
924 NO ADVERSE EVENT 128 0.0014
925 CARDIOVASCULAR DISORDER 30 0.0014
926 DRUG PRESCRIBING ERROR 26 0.0013
927 CORONARY ARTERY DISEASE 36 0.0013
928 VERTIGO 61 0.0013
929 DEPRESSION 237 0.0013
930 CONDITION AGGRAVATED 235 0.0013
931 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 51 0.0013
932 VISUAL IMPAIRMENT 105 0.0013
933 DYSKINESIA 39 0.0013
934 EMOTIONAL DISORDER 31 0.0013
935 ANGER 34 0.0013
936 MOOD SWINGS 32 0.0013
937 SHOCK 20 0.0013
938 END STAGE RENAL DISEASE 19 0.0012
939 ARTHRITIS 65 0.0012
940 HYPERHIDROSIS 116 0.0012
941 INTERVERTEBRAL DISC PROTRUSION 20 0.0012
942 PAIN OF SKIN 24 0.0012
943 RESTLESSNESS 32 0.0012
944 AGITATION 68 0.0012
945 PRODUCT DOSE OMISSION 78 0.0012
946 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 131 0.0011
947 BALANCE DISORDER 73 0.0011
948 VISION BLURRED 108 0.0011
949 INTENTIONAL PRODUCT USE ISSUE 51 0.0011
950 PROCEDURAL PAIN 20 0.0011
951 FEAR 24 0.0011
952 SKIN IRRITATION 38 0.0011
953 SURGERY 36 0.0011
954 THROAT TIGHTNESS 20 0.0010
955 MYOCARDIAL INFARCTION 152 0.0010
956 DRUG HYPERSENSITIVITY 147 0.0010
957 ACTIVITIES OF DAILY LIVING IMPAIRED 20 0.0010
958 INCORRECT DOSE ADMINISTERED 114 0.0010
959 ADVERSE DRUG REACTION 50 0.0010
960 MENTAL DISORDER 29 0.0010
961 ARTHROPATHY 35 0.0009
962 TRANSIENT ISCHAEMIC ATTACK 25 0.0009
963 EYE PAIN 32 0.0009
964 HALLUCINATION 44 0.0009
965 INJECTION SITE PAIN 166 0.0009
966 INJECTION SITE SWELLING 43 0.0009
967 VISUAL ACUITY REDUCED 24 0.0008
968 DISTURBANCE IN ATTENTION 33 0.0008
969 BRADYCARDIA 32 0.0008
970 TINNITUS 26 0.0008
971 ANAPHYLACTIC REACTION 27 0.0008
972 MUSCULOSKELETAL STIFFNESS 45 0.0008
973 VAGINAL HAEMORRHAGE 26 0.0007
974 DRUG EFFECT INCOMPLETE 24 0.0007
975 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0007
976 INJURY 37 0.0006
977 EYE IRRITATION 21 0.0006
978 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
979 TREATMENT NONCOMPLIANCE 19 0.0006
980 INJECTION SITE BRUISING 28 0.0005
981 UNDERDOSE 26 0.0005
982 UNEVALUABLE EVENT 28 0.0005
983 PSORIASIS 41 0.0005
984 ADVERSE EVENT 30 0.0005
985 OVERDOSE 63 0.0004
986 INJECTION SITE HAEMORRHAGE 22 0.0004
987 DRUG DOSE OMISSION 68 0.0004
988 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0004
989 SKIN BURNING SENSATION 21 0.0004
990 INJECTION SITE ERYTHEMA 32 0.0004
991 SUICIDAL IDEATION 24 0.0003
992 EMOTIONAL DISTRESS 21 0.0003
993 PRODUCT QUALITY ISSUE 30 0.0003